サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1635878

性感染症（STD）診断市場レポート：タイプ別、デバイスタイプ別、エンドユーザー別、地域別、2025-2033年

Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type (Laboratory Devices, Point of Care Devices), End User (Laboratory Testing, Point of Care Testing), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
性感染症（STD）診断市場レポート：タイプ別、デバイスタイプ別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年01月10日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

性感染症（STD）診断の世界市場規模は、2024年に1,090億米ドルに達しました。今後、IMARC Groupは、2033年までに市場は1,649億米ドルに達し、2025～2033年の成長率（CAGR）は4.47%になると予測しています。性病の有病率の上昇、早期診断に関する大衆の意識の高まり、家庭用性病検査キットのイントロダクションなどが市場を牽引する主な要因です。

性感染症（STD）診断とは、STDの存在を特定・確認するために行われる検査、試験、綿棒培養を指します。これには、特定のSTDの抗体や抗原の存在を検出するための血液、体液サンプル、尿検査が含まれます。性器ヘルペス、クラミジア、淋病、梅毒、陰部シラミ、トリコモナス、後天性免疫不全症候群（AIDS）、細菌性膣炎、疥癬、下疳など、様々な性感染症や感染症の検出やスクリーニングに広く使用されています。STD診断は、早期発見と正確な治療を助け、不妊症を予防し、胎児を感染から守り、病気の蔓延を最小限に抑えます。これらの診断法はまた、長期的なリスクの可能性を減らし、自信を高め、医師が病気やその原因について貴重な洞察を得ることにも役立ちます。

性感染症（STD）診断市場の動向：

無防備な性交渉や薬物乱用による性感染症（STD）の有病率の上昇は、市場成長を促進する重要な要因の一つです。STD診断薬は、細菌、ウイルス、寄生虫などの様々なSTD原因物質を高い精度と信頼性で検出するために広く使用されており、医療プロバイダーが適切な治療を決定し、母親から乳幼児への疾患伝染を予防し、患者の臨床転帰を改善するのに役立っています。これに加えて、不妊症、先天性障害、がん、失明、骨の奇形、脳の損傷、精神遅滞などの長期的な合併症を予防できるSTDの早期発見・診断に関する大衆の意識の高まりが、もう一つの成長促進要因として作用しています。さらに、教育キャンペーン、セミナー、ソーシャルメディア広告を通じて、性の健康と性病検査に関する意識を高め、それに関連する社会的偏見を取り除くためのさまざまな政府イニシアチブの実施が、市場成長に弾みをつけています。さらに、費用対効果が高く、安全で正確かつ便利で、結果が早く得られ、プライバシーが保たれる家庭用STD検査キットの導入が、市場成長にプラスの影響を与えています。さらに、個人の陰部のデジタル画像を分析することで性病を診断できる人工知能（AI）ベースのモバイルアプリケーションの最近の開発は、性病検査へのアクセスを改善し、機密性を維持し、個人データを保護することで、市場の成長に好影響を与えています。ヘルスケア産業の著しい成長、eコマースプラットフォームでのSTD診断キットの容易な入手、新規診断技術の研究開発（R&D）への投資の増加など、その他の要因も市場成長を促進すると予測されます。

本レポートで扱う主な質問

  • 世界の性感染症（STD）診断市場はこれまでどのように推移してきたか？
  • 世界の性感染症（STD）診断市場における市場促進要因、市場抑制要因、市場機会は何か？
  • それぞれの促進要因、抑制要因、機会が世界の性感染症（STD）診断市場に与える影響は？
  • 主要な地域市場とは？
  • 性感染症（STD）診断市場で最も魅力的な国はどこか？
  • タイプ別の市場内訳は？
  • 性感染症（STD）診断市場で最も魅力的なタイプは？
  • デバイスタイプ別の市場内訳は？
  • 性感染症（STD）診断市場における最も魅力的なデバイスタイプは？
  • エンドユーザー別の市場内訳は？
  • 性感染症（STD）診断市場で最も魅力的なエンドユーザーは？
  • 性感染症（STD）診断世界市場の競合構造は？
  • 性感染症（STD）診断の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界性感染症（STD）診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • クラミジア検査
    • 市場動向
    • 市場予測
  • 梅毒検査
    • 市場動向
    • 市場予測
  • 淋病検査
    • 市場動向
    • 市場予測
  • 単純ヘルペスウイルス検査
    • 市場動向
    • 市場予測
  • ヒトパピローマウイルス検査
    • 市場動向
    • 市場予測
  • ヒト免疫不全ウイルス検査
    • 市場動向
    • 市場予測
  • 軟性下疳検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：デバイスタイプ別

  • 実験装置
    • 市場動向
    • 主要セグメント
      • サーマルサイクラー-PCR
      • ラテラルフローリーダー
      • フローサイトメーター
      • 吸光マイクロプレートリーダー- 酵素結合免疫吸着測定法（ELISA）
      • その他
    • 市場予測
  • ポイントオブケア（PoC）デバイス
    • 市場動向
    • 主要セグメント
      • 電話チップ（マイクロ流体+ICT）
      • ポータブル/ベンチトップ/迅速診断キット
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 臨床検査
    • 市場動向
    • 市場予測
  • ポイントオブケア（PoC）検査
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton Dickinson and Company
    • BioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Cepheid（Danaher Corporation）
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • Qiagen N.V.
    • Quidel Corporation
    • Siemens Healthineers AG（Siemens AG）
図表

List of Figures

  • Figure 1: Global: Sexually Transmitted Disease Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Device Type (in %), 2024
  • Figure 6: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Sexually Transmitted Disease Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Sexually Transmitted Disease Diagnostics Industry: Value Chain Analysis
  • Figure 83: Global: Sexually Transmitted Disease Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sexually Transmitted Disease Diagnostics Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
  • Table 4: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Sexually Transmitted Disease Diagnostics Market: Competitive Structure
  • Table 7: Global: Sexually Transmitted Disease Diagnostics Market: Key Players
目次
Product Code: SR112025A6956

The global sexually transmitted disease (STD) diagnostics market size reached USD 109.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 164.9 Billion by 2033, exhibiting a growth rate (CAGR) of 4.47% during 2025-2033. The rising prevalence of STDs, increasing awareness among the masses regarding early diagnosis, and the introduction of at-home STD testing kits represent some of the key factors driving the market.

Sexually transmitted disease (STD) diagnostics refer to examinations, tests, and swab cultures performed to identify and confirm the presence of STDs. It includes blood, fluid sample, and urine tests to detect the presence of antibodies or antigens of certain STDs. It is widely used to detect and screen various sexually transmitted diseases and infections, such as genital herpes, chlamydia, gonorrhea, syphilis, pubic lice, trichomoniasis, acquired immune deficiency syndrome (AIDS), bacterial vaginosis, scabies, and chancroid. STD diagnostics aids in early detection and accurate treatment, prevents infertility, protects unborn children from infection, and minimizes the spread of diseases. These diagnostic methods also help in reducing the chance of long-term risks, boosting confidence, and providing physicians with valuable insight into diseases and their causes.

Sexually Transmitted Disease (STD) Diagnostics Market Trends:

The rising prevalence of sexually transmitted diseases (STDs) due to unprotected sexual intercourse and drug abuse is one of the key factors driving the market growth. STD diagnostics are widely used to detect various STD-causing agents, such as bacteria, viruses, and parasites, with high accuracy and reliability that aids healthcare providers in determining suitable treatment, preventing disease transmission from mothers to infants, and improving clinical outcomes for patients. In addition to this, the increasing awareness among the masses regarding early detection and diagnosis of STDs, which can prevent long-term complications, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to the market growth. Additionally, the introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the market growth. Moreover, the recent development of artificial intelligence (AI) - based mobile applications that can diagnose STDs by analyzing digital images of an individual's private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development (R&D) of novel diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

Type Insights:

  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing
  • Others

Device Type Insights:

  • Laboratory Devices
  • Thermal Cycler - PCR
  • Lateral Flow Readers
  • Flow Cytometers
  • Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
  • Others
  • Point of Care (PoC) Devices
  • Phone Chips (Microfluidics + ICT)
  • Portable/Bench Top/Rapid Diagnostic Kits

End User Insights:

  • Laboratory Testing
  • Point of Care (PoC) Testing

Regional Insights:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for sexually transmitted disease (STD) diagnostics. Some of the factors driving the North America sexually transmitted disease (STD) diagnostics market included the rising prevalence of STDs, extensive research and development (R&D) activities, and significant growth in the healthcare industry.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global sexually transmitted disease (STD) diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global sexually transmitted disease (STD) diagnostics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global sexually transmitted disease (STD) diagnostics market?
  • What is the impact of each driver, restraint, and opportunity on the global sexually transmitted disease (STD) diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the device type?
  • Which is the most attractive device type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the sexually transmitted disease (STD) diagnostics market?
  • What is the competitive structure of the global sexually transmitted disease (STD) diagnostics market?
  • Who are the key players/companies in the global sexually transmitted disease (STD) diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sexually Transmitted Disease (STD) Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Chlamydia Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Syphilis Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gonorrhea Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Herpes Simplex Virus Testing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Human Papilloma Virus Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Human Immunodeficiency Virus Testing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Chancroid Testing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Laboratory Devices
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Thermal Cyclers - PCR
      • 7.1.2.2 Lateral Flow Readers
      • 7.1.2.3 Flow Cytometers
      • 7.1.2.4 Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Point of Care (PoC) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Phone Chips (Microfluidics + ICT)
      • 7.2.2.2 Portable/Bench Top/Rapid Diagnostic Kits
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Laboratory Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Point of Care Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 BioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid (Danaher Corporation)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Hologic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Qiagen N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Quidel Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens Healthineers AG (Siemens AG)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.